Passage Raises $4M To Help Developers Bring Biometric Authentication To The Masses
Amount Raised
$4 Million
Round Type
Seed
United StatesBiotechnologyHealthcareHealth CareGeneticsTherapeuticsDescription
Passage, an innovator in the rapidly growing passwordless identity space, today emerged from stealth announcing the availability of its public beta along with $4 million of new funding led by LiveOak Venture Partners with participation from Next Coast Ventures, Tau Ventures, Secure Octane, and various angel investors. Passage takes a developer-first and biometric-first approach to passwordless authentication, enabling users to log in to web applications with Face ID, Touch ID, Windows Hello, and other biometrics built into their devices.
Quick answer
Passage Bio raised $4 Million in a Seed round, dated February 1, 2022. Passage Bio is based in United States.
- How much did Passage Bio raise?
- Passage Bio raised $4 Million in a Seed round on February 1, 2022.
- What does Passage Bio do?
- Passage Bio, Inc. (NASDAQ: PASG) is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases.
- Where is Passage Bio based and how big is it?
- Passage Bio is based in United States. Fundz records about 83 employees.
- Who are the decision-makers at Passage Bio?
- Fundz holds 1 contact at Passage Bio, including the Chief Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Genetics around the same time
Companies in the same sectors as Passage Bio that raised within 45 days of this round, from Fundz verified event records.
- Azora Therapeutics, Inc. (DE) raised $10M on February 17, 2022.
- Azora Therapeutics, Inc. (DE) raised $10M (Funding Round) on February 16, 2022.
- MindImmune Therapeutics raised $5.3M on February 4, 2022.
- Enliven Therapeutics raised an undisclosed amount (Funding Round) on January 19, 2022.
- Tessera Defense & Homeland Security Inc. raised $3M (Seed) on January 4, 2022.
- Arbutus raised $15M on December 30, 2021.
Who to call at Passage Bio, and when
A new round usually means Passage Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Passage Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Passage Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Passage Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Passage Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Passage Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.